The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Feb. 27, 2017
Applicant:

Biolitec Unternehmensbeteiligungs Ii Ag, Vienna, AT;

Inventors:

Michael Staegemann, Berlin, DE;

Rainer Haag, Berlin, DE;

Arno Wiehe, Berlin, DE;

Susanna Graefe, Jena, DE;

Burkhard Gitter, Jena, DE;

Volker Albrecht, Nuthetal, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/38 (2006.01); A61K 31/40 (2006.01); C07D 487/22 (2006.01); A61K 41/00 (2020.01); C07D 403/14 (2006.01); A61K 47/60 (2017.01); C08G 65/48 (2006.01);
U.S. Cl.
CPC ...
C07D 487/22 (2013.01); A61K 41/0071 (2013.01); A61K 47/60 (2017.08); C07D 403/14 (2013.01); C08G 65/48 (2013.01);
Abstract

Biologically active compounds that can be used as photosensitizers for diagnostic and therapeutic applications, particularly for PDT of cancer, infections and other hyperproliferative diseases, fluorescence diagnosis and PDT treatment of a non-tumorous indication such as arthritis, inflammatory diseases, viral or bacterial infections, dermatological, ophthalmological or urological disorders are provided as well as providing methods to obtain them in pharmaceutical quality. In addition, conjugates are provided in which these photosensitizers are attached to water-soluble polymers via cleavable linkers that can be cleaved in the body under specific conditions. Another embodiment consists of formulating the desired tetrapyrrole photosensitizer into a pharmaceutical formulation to be injected into the body avoiding undesirable effects like solubility problems or delayed pharmacokinetics of the tetrapyrrole systems.


Find Patent Forward Citations

Loading…